Dr. Philip Bull and Dr. Alan Hakim, in partnership with Long Covid advocate, Gez Medinger, are conducting new research looking at whether generalized (widespread) joint hypermobility may be a risk factor in adults for certain chronic symptoms in Long COVID.
Initial findings of the study found that generalized joint hypermobility (GJH) was more common than might be expected in people with Long COVID. Among the complications of Long COVID, people with GJH were more likely to report significant joint, muscle, and nerve pain, and brain fog compared to people who were not hypermobile. Joint hypermobility may be a risk for neuromuscular symptoms in Long COVID.
This research is in its early stages and has not been peer-reviewed, but further information is available about the study in-depth on the HMSA website here.
